Stem Cell Therapy in Delhi

Stem cell therapy in Delhi and ovarian rejuvenation are emerging regenerative options for patients facing diminished ovarian reserve, premature ovarian insufficiency, thin endometrium, Asherman’s syndrome, and non-obstructive azoospermia. At Mediworld Fertility in Delhi, our clinical team offers protocols such as ovarian stem cell therapy, hysteroscopic stem cell therapy, and PRP-based ovarian rejuvenation alongside IVF and ICSI pathways.

What is Stem Cell Therapy for Fertility?

Stem cell therapy in Delhi for fertility uses regenerative cells, most often mesenchymal stem cells from bone marrow, fat tissue, or umbilical cord, to repair damaged reproductive tissue. The cells release growth factors that improve blood supply, reduce scarring, and stimulate the body’s own repair process inside the ovaries or uterine lining.

In fertility care, the goal is targeted: bring back ovarian activity in women with very low egg reserve, rebuild a lining thick enough for an embryo to implant, or support spermatogenesis in men with severely impaired sperm production. The cells are delivered either by intraovarian injection, intrauterine infusion, or, in some male infertility cases, intratesticular injection. Adipose-derived stem cells have been shown to improve endometrial thickness, blood vessel formation, and receptivity in patients with thin lining and Asherman’s syndrome.

It’s worth saying clearly: this isn’t a magic switch. It’s a clinical intervention that works best when combined with proper diagnostics, the right patient selection, and a well-planned IVF or ICSI treatment cycle to follow.

Who is a Candidate for Stem Cell-Based Fertility Treatment?

Good candidates include women with diminished ovarian reserve, premature ovarian insufficiency (early menopause before 40), thin or unresponsive endometrium, Asherman’s syndrome (uterine scarring), and repeated implantation failure after two or more IVF transfers. In men, regenerative options are being studied for non-obstructive azoospermia. Candidacy depends on age, AMH, prior cycles, and overall reproductive health.

Not every patient is a fit. Women with completely absent ovaries, severe genetic causes of infertility, or active pelvic infection won’t benefit. Age plays a role, but not as rigidly as people assume. We’ve seen women in their early 40s with a measurable AMH improvement after PRP-based ovarian rejuvenation, and others in their mid-30s where the ovarian tissue simply didn’t respond.

The starting point is a thorough fertility workup: AMH, FSH, antral follicle count, hormone profile, hysteroscopy where indicated, and for men, a detailed semen analysis with hormonal and genetic evaluation. Patients with repeated pregnancy loss often overlap with this group, which is why we evaluate them alongside our recurrent pregnancy loss care pathway. Women with PCOD treatment needs may also be assessed for regenerative adjuncts, although the priorities are different.

How Regenerative Therapies Are Used in Fertility Care

Regenerative fertility treatments aim to improve ovarian, uterine, or testicular function in patients with complex fertility challenges.

• Ovarian rejuvenation uses PRP or stem cell-based therapies to support follicle activation and improve ovarian response.
• Stem cell therapy for thin endometrium and Asherman’s syndrome focuses on rebuilding the uterine lining and improving implantation potential.
• MSC therapy for repeated implantation failure is being explored to improve endometrial receptivity and pregnancy outcomes.
• Stem cell research in severe male infertility (NOA) has shown early potential in restoring sperm production in selected cases.
• PRP therapy uses growth factors from the patient’s own blood to support tissue repair and is one of the most widely used regenerative fertility approaches today.

What Does the Clinical Evidence Show?

The strongest evidence so far is for thin endometrium and Asherman’s syndrome, where MSC therapy reliably improves lining thickness and pregnancy outcomes. Evidence for ovarian rejuvenation is positive but mixed, with most studies being observational rather than randomised. Male infertility data is the earliest stage, with promising Phase I results in azoospermia and ongoing trials.

The honest picture: regenerative fertility therapy works best when it’s used for the right indication, on the right patient, by an experienced team. It is not a guaranteed answer for every infertility case. Many of the published studies are single-arm or small in size, which is why patient selection and informed consent matter so much. As of 2021, ClinicalTrials.gov already listed 17 trials specifically on stem cells for premature ovarian failure, and that number has grown since.

For most patients, regenerative therapy works best as a step that improves the conditions for a subsequent IVF treatment in Delhi, rather than as a standalone treatment.

Stem Cell Therapy Regulations in India: What Fertility Patients Should Know

In India, stem cell therapy in Delhi for fertility treatment is still considered investigational under the ICMR-DBT National Guidelines for Stem Cell Research. At present, only bone marrow transplantation is fully approved, while regenerative fertility treatments such as ovarian stem cell therapy, PRP therapy, and endometrial regenerative procedures must be performed with proper ethical oversight and informed patient consent.

For patients exploring stem cell therapy for infertility in Delhi, this makes clinic transparency extremely important. A responsible fertility centre will clearly explain the current evidence, possible benefits, limitations, and realistic success expectations before starting treatment.

At Mediworld Fertility, every regenerative fertility treatment plan is built around evidence-based fertility care. Dr. Neha Gupta and the team carefully evaluate whether stem cell therapy, PRP treatment, IVF, donor programs, or surrogacy offers the most appropriate path forward based on your diagnosis and fertility goals.

Meet the Specialist Behind Your Stem Cell Therapy at Mediworld

Your regenerative fertility care at Mediworld is led by Dr. Neha Gupta, Clinical Director and Senior Consultant in IVF and reproductive medicine. With over 21 years of clinical experience, Dr. Gupta has helped more than 2,000 couples achieve parenthood, and she is among the few fertility specialists in Delhi NCR with structured expertise in ovarian stem cell therapy, ovarian rejuvenation, and hysteroscopic stem cell therapy.

Her work focuses on the most difficult fertility cases: poor responders, women with repeated implantation failure, low AMH, thin endometrium, recurrent miscarriage, and high-risk pregnancies. Dr. Gupta also manages advanced reproductive techniques including IVF with PGD/PGS genetic testing, blastocyst culture and transfer, donor egg and donor sperm programs, TESE and Micro-TESE for male infertility, and fertility preservation for cancer patients.

Patients who need a regenerative protocol combined with embryology work also have access to Dr. Sushma Ved, our senior IVF specialist and embryologist with over two decades of experience and more than 6,000 IVF-ICSI cycles to her name. Dr. Ved’s expertise becomes particularly relevant where stem cell or PRP therapy is followed by an IVF or ICSI cycle, since lab quality and embryo handling decide much of what happens next.

You can read more about the wider team on the Mediworld fertility specialists page.

Stem Cell Therapy Cost in Delhi

Stem cell therapy cost in Delhi for fertility patients ranges from ₹25,000 to ₹40,000 per session for PRP-based ovarian rejuvenation, and from ₹1.5 lakh to ₹4 lakh or more for full ovarian stem cell therapy protocols. The wide range reflects differences in cell source (bone marrow versus adipose versus umbilical cord), lab processing, anaesthesia, whether the procedure is done by transvaginal injection or laparoscopy, and how many sessions are needed.

A few things affect what you’ll actually pay:

• Type of regenerative protocol: PRP is the most affordable starting point. Full autologous stem cell transplant in the ovary, where bone marrow is harvested and processed in a GMP-compliant lab, costs significantly more because of the laboratory infrastructure involved.
• Diagnostic workup: AMH, FSH, AFC, hysteroscopy, hormonal panels, and where relevant semen analysis and genetic tests, all sit outside the procedure itself.
• Number of sessions: Some patients respond to a single PRP session. Others may need a second or third, spaced over months.
• Combination with IVF or ICSI: Most patients who undergo ovarian stem cell therapy or hysteroscopic stem cell therapy go on to do an IVF or ICSI cycle within three to six months, which adds the cost of that cycle.
• Anaesthesia and hospital stay: Laparoscopic delivery, sedation, and any overnight stay influence the final bill.

For an exact estimate based on your diagnosis and previous cycle history, our team can prepare a personalised cost plan after the first consultation. You can also explore related fertility treatment costs at Mediworld for context on IVF, ICSI, and egg freezing pricing.

How Mediworld Fertility Approaches Regenerative Fertility Care

At Mediworld, regenerative therapy starts with diagnostics, not a sales pitch. We review your AMH, AFC, ovarian response history, endometrial behaviour across cycles, and any prior IVF or ICSI outcomes before recommending a regenerative protocol. Where the evidence supports it, we offer ovarian rejuvenation, hysteroscopic stem cell therapy, or PRP-assisted endometrial preparation. Where it doesn’t, we say so.

This integrated approach matters because regenerative care rarely stands alone. A patient who undergoes ovarian rejuvenation usually moves into a stimulated IVF or ICSI cycle within three to six months, to capture any improvement in follicle quality while it lasts. A patient with Asherman’s syndrome who has hysteroscopic stem cell therapy needs a carefully timed frozen embryo transfer afterwards. Our protocols are designed to sequence these steps so nothing is wasted.

For patients where regenerative therapy is unlikely to succeed (severe uterine factor, very advanced maternal age with no residual ovarian activity, complete genetic causes of azoospermia), we present alternative pathways honestly, including donor programs and surrogacy options. The aim is always to find the route most likely to give you a baby, not to push a particular treatment.

International Patients Seeking Regenerative Fertility Care at Mediworld

We support international patients across every step of their regenerative fertility journey. Initial consultations are conducted remotely over video so that your case can be reviewed before you travel. Once you share your previous reports, scans, and prior treatment history securely, our team prepares a preliminary plan and indicative cost estimate so you know what to expect.

Travel and stay coordination is handled by our international patient desk: visa documentation, airport pickup, accommodation near our Mediworld centres across Delhi NCR in Safdarjung Enclave, Sukhdev Vihar, Faridabad, Ghaziabad, and Greater Noida, and on-call support throughout your stay. Language assistance is available for patients from non-English-speaking regions.

After the procedure, post-treatment monitoring continues remotely. Hormone levels, ultrasound follow-ups, and any IVF or ICSI cycle that follows can be coordinated with a local provider in your home country, with our team reviewing reports and guiding next steps.

Building a Realistic Fertility Plan with Regenerative Medicine

Stem cell therapy is not a cure-all, and we don’t pretend otherwise. But for the right patient, with the right diagnosis, in experienced hands, regenerative fertility care can change outcomes that conventional treatment has not been able to shift. Thin endometrium, low AMH, repeated implantation failure, and even severe male factor have all responded to regenerative protocols in published studies.

The right next step is a clinical evaluation, not a decision made in isolation. Book a consultation with Dr. Neha Gupta and the Mediworld team to review your reports, understand whether regenerative therapy fits your case, and build a treatment plan that gives you a realistic path forward.

Frequently Asked Questions

1. Is stem cell therapy approved for fertility treatment in India?

Outside of bone marrow transplantation, stem cell therapy in India is classified as investigational under the ICMR-DBT National Guidelines for Stem Cell Research 2017. For fertility, this means regenerative protocols are offered under structured clinical supervision with informed consent. Patients should always confirm a clinic’s protocols, evidence base, and consent process before starting treatment.

2. Can stem cell therapy help women with low AMH or premature ovarian failure?

There is encouraging early evidence. A 2025 research paper using G-CSF stem cell mobilisation combined with intraovarian stem cell factor-enriched PRP showed improvements in oocyte activation in women with ovarian failure. Results vary, and the therapy works best when followed by a planned IVF cycle to capture any responsive follicles.

3. How is stem cell therapy different from PRP for ovarian rejuvenation?

PRP uses concentrated platelets from your own blood, rich in growth factors, injected into the ovaries to stimulate dormant follicles. Stem cell therapy uses regenerative cells (from bone marrow, adipose tissue, or umbilical cord) that can differentiate and signal repair more broadly. PRP is simpler, faster, and less expensive. Stem cell protocols are more complex, more expensive, and still under active clinical research.

4. Does stem cell therapy work for men with azoospermia?

Early research is promising. In one Phase I clinical trial, 22.5% of men with non-obstructive azoospermia had detectable sperm in their semen six months after autologous bone marrow stem cell treatment, along with improved testosterone and inhibin B levels. This is small-scale data, and most men with NOA still need ICSI treatment with surgically retrieved sperm to achieve a pregnancy.

5. How much does stem cell therapy for fertility cost in Delhi?

PRP-based ovarian rejuvenation typically costs ₹25,000 to ₹40,000 per session in Delhi. Full ovarian stem cell therapy protocols using bone marrow or other cell sources range from ₹1.5 lakh to ₹4 lakh, depending on cell processing, anaesthesia, delivery method, and number of sessions. Cost increases when combined with an IVF or ICSI cycle. A personalised estimate is provided after the initial fertility workup.

6. Can stem cell therapy replace IVF, or is it used alongside it?

For most patients, stem cell therapy is not a replacement for IVF. It’s used to improve the conditions for a successful IVF or ICSI cycle, by reactivating ovarian follicles, rebuilding endometrial lining, or supporting spermatogenesis. A small number of patients conceive naturally after regenerative therapy, but the standard expectation is that stem cell or PRP